Super Session 2 – Neurosciences

Latest developments in neurosciences R&D

Super Session 2 – Neurosciences

14:00 - 15:30 Plenary Room A

CNS diseases continue to pose immense burdens on both patients and society as a whole. But despite enormous amount of research most of current treatments only temporarily improve symptoms. What is needed to accelerate the development? Who is willing to invest in the neuroscience development projects despite all setbacks? And can we expect breakthroughs the coming years that will change the way we will address the neurosciences area?  International experts will share their views on what is expected and possible based on currently available knowledge.

Hosted by:

Adlersson Heath

Adlersson Heath

Sponsored by:

MSD

MSD

Moderator(s): Ms. Ingrid Heath - Partner, Adlersson & Heath

Speaker(s):
Dr. Jina Elise Swartz - Global Clinical Development, MSD Dr. Per-Ola Freskgård - Vice Director & Distinguished Scientist Neuroscience, pRED Roche Innovation Center Dr. Roman Lassnig - Development Engineer, Printed Electronics, Biocom Lab/RISE Dr. Patrick Sobocki - Investment Manager, Industrifonden Dr. Steffen Thirstrup - Director, NDA Regulatory Advisory Board

full program